| Authors: |
Marconato M; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, Tübingen, Germany; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany., Hackenbruch C; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, Tübingen, Germany; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany., Jäger S; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany., Göpel S; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany., Кirieieva T; Communal Non-Profit Enterprise 'City clinical hospital' of Dnipro city council, Therapy Department, Dnipro State Medical University, Dnipro, Ukraine., Gavrylov A; Municipal Non-Profit Enterprise of Regional Council Regional Clinical Infectious Hospital, Kharkiv, Ukraine., Fricke H; CORAT Therapeutics GmbH, Braunschweig, Germany., Hust M; Department of Medical Biotechnology, Technische Universität Braunschweig, Braunschweig, Germany; Department of Biotechnology, Technische Universität Braunschweig, Braunschweig, Germany., Dübel S; Department of Biotechnology, Technische Universität Braunschweig, Braunschweig, Germany., Dings C; Saarmetrics GmbH, Saarbrücken, Germany., Lehr T; Saarmetrics GmbH, Saarbrücken, Germany; Clinical Pharmacy, Saarland University, Saarbrücken, Germany., Cuevas M; TUD Dresden University of Technology, Faculty of Medicine (and University Hospital), Carl Gustav Carus Department of Otorhinolaryngology Head and Neck Surgery, Dresden, Germany., Bitzer M; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany., Klein C; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany., Schwab M; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, Tübingen, Germany; Departments of Clinical Pharmacology, and of Biochemistry and Pharmacy, University Tuebingen, Tuebingen, Germany; German Cancer Consortium (DKTK), partner site Tuebingen, a partnership between DKFZ and University Hospital Tuebingen, Tuebingen, Germany., Wirtz H; Universitätsklinikum Leipzig Medizinische Klinik II, Leipzig, Germany., Schneider J; Department of Internal Medicine II, TUM University Hospital Rechts der Isar, Technical University of Munich, Munich, Germany., Bitter T; Städtisches Klinikum Braunschweiq qGmbH Med. Klinik VII Klinik für Pneumoloqie und Beatmungsmedizin, Braunschweiq Germany., Frenzel A; CORAT Therapeutics GmbH, Braunschweig, Germany., Dhaen MA; CORAT Therapeutics GmbH, Braunschweig, Germany., Herrmann A; CORAT Therapeutics GmbH, Braunschweig, Germany., Jung G; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany., Walz JS; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, Tübingen, Germany; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; German Cancer Consortium (DKTK), partner site Tuebingen, a partnership between DKFZ and University Hospital Tuebingen, Tuebingen, Germany., Salih HR; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, Tübingen, Germany; German Cancer Consortium (DKTK), partner site Tuebingen, a partnership between DKFZ and University Hospital Tuebingen, Tuebingen, Germany., Heitmann JS; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, Tübingen, Germany; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany. Electronic address: jonas.heitmann@med.uni-tuebingen.de. |
